SARS-CoV-2 antibody assays: key factors for test selection and interpretation

T.AwT.Aw
BulletArticle
Share this:
Copy link
Prof_AW_webinar_photo

What is the role of serology testing in management of the COVID-19 pandemic? While researchers work to validate new assays and understand the relationship between antibody response and immunity to the SARS-CoV-2 virus, many uncertainties remain about how to apply serology testing.

This recent webinar by Professor Tar Choon Aw, Senior Consultant and Director of Chemical Pathology in the Department of Laboratory Medicine at Changi General Hospital in Singapore, presents some of the latest data in this fast-changing field, as well as key considerations when selecting and interpreting serology tests.

Share this:
Copy link

More on same topic

COVID-19 testing in Asia: how government policy shapes access to PCR diagnostics

COVID-19 testing in Singapore: key updates from a public hospital lab

Recommended topics

SequencingRED 2020Rare Diseases
Next Read
  • C-Suite Perspectives, Event Coverage, Healthcare Transformation, Management, RED 2024
Dr William Morice II’s visions and considerations for building a global diagnostics ecosystem
How Awanui Group drives diagnostic excellence in New Zealand: Q&A with Anoop Singh (Part 1)
  • C-Suite Perspectives, Leaders In Conversation, Management
Awanui Group’s quest to improve lab diagnostics in New Zealand: Q&A with Anoop Singh (Part 1)
‘Real world evidence’ and clinical labs: a brief introduction
  • Healthcare Transformation, Management, Operations, Population Health Management
‘Real world evidence’ and clinical labs: a brief introduction
‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)
  • Disease Area, Healthcare Transformation, Histopathology, Leaders In Conversation, Management, Oncology, Operations
‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)
Scroll to Top